Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Share Price (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
12.75    -0.25 (-1.92%)
Bid:
12.00
Ask:
13.50
Spread: 1.50 (12.50%)
Market Cap: £15.94m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Fusion Antibodies Share Price
Price 12.75 Open 12.75
Bid 12.00 High 13.00
Ask 13.50 Low 12.75
Change -0.25 (-1.92%) Close 13.00
Volume 167,244
Currency GBX
Issue Country GB
Shares in Issue 125.02m
Market Cap £15.94m
PE Ratio -7.083333
EPS -1.80
Year High 20.50
Year High Date 24-Sep-2025
Year Low 6.10
Year Low Date 09-Jul-2025
Dividend 0.00
Yield 0.00%
# Trades 12
Vol. Sold 136,266
Sold Value £16.87k
Vol. Bought 11,558
Bought Value £1.50k
Market Size 30,000
What if I invested £1,000 in Fusion Antibodies?
£ 944.44 (-5.56%)
1 month ago
£ 944.44 (-5.56%)
3 months ago
£ 836.07 (-16.39%)
6 months ago
£ 1,917.29 (+91.73%)
1 year ago
Add FAB to WatchlistAdd FAB to Watchlist

Compare Broker Offers

Selected partners may offer promotions for new customers. We may earn a referral fee if you open an account

Great for:
Active Traders
View Offer
Capital at risk
Great for:
Copy Trading
View Offer
Other fees apply.
Capital at risk.
Great for:
ISAs & SIPPs
View Offer
Capital at risk
Great for:
Beginner Friendly
View Offer
Capital at risk
Fusion Antibodies Plc Ord 4p

Fusion Antibodies is listed in the FTSE AIM All-Share index.

Fusion Antibodies is listed in the Health Care and Related Services sector.

Fusion Antibodies Plc Ord 4p is listed on the London Stock Exchange trading with ticker code FAB.L. It has a market capitalisation of £15.94m, with approximately 125.02m shares in issue. Over the last year, Fusion Antibodies share price has been traded in a range of 14.40, hitting a high of 20.50, and a low of 6.10.

Fusion Antibodies plc, established in 2001 and headquartered in Belfast, Northern Ireland, is a contract research organisation specialising in antibody development services. They offer end-to-end solutions from antigen design to cell line development, including antibody humanization, affinity maturation, and protein engineering. Their proprietary technology platforms, such as CDRx® for antibody humanisation and RAMP® for affinity maturation, support the development of pre-clinical biologics. The company's shares have been traded on AIM since December 2017.

Some Videos You Might Like

Mike Ralston, CEO at Blenco...


 

Wishbone Gold announce 2025...


What's Hot 17th March 2026


Recent Share Trades for Fusion Antibodies (FAB)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
05-Jun-2616:12:0012.0515,000Sell*12.0013.501,808O Ordinary
05-Jun-2615:50:5112.2020,000Sell*12.0013.502,440O Ordinary
05-Jun-2615:02:2312.9511,552Buy*12.0013.501,496O Ordinary
05-Jun-2611:15:3312.22230,000Sell*12.0013.503,667O Ordinary
05-Jun-2609:49:4112.2224,049Sell*12.0013.50494.87O Ordinary
05-Jun-2609:16:5512.5030,000Sell*12.0013.503,750O Ordinary
05-Jun-2609:16:5312.00119Sell*12.0013.5014.28O Ordinary
Trade was executed as an SI
05-Jun-2609:00:1913.0019,420Unknown*12.5013.502,525O Ordinary
05-Jun-2608:35:5612.6537,065Sell*12.5013.504,689O Ordinary
05-Jun-2608:11:1513.506Buy*12.5013.500.81O Ordinary

Directors Deals for Fusion Antibodies (FAB)

Announced Traded Action Notifier Price Currency Amount Holding
17-Feb-2617-Feb-26Transfer ToSimon Gordon Douglas held the position of Chairman at the time of this trade.Simon Gordon Douglas0.00200,000861,062
17-Feb-2617-Feb-26Transfer ToSimon Gordon Douglas held the position of Chairman at the time of this trade.Simon Gordon Douglas0.00200,000861,062
11-Jul-2507-Jul-25Transfer FromColin Walsh held the position of Non-Executive Director at the time of this trade.Colin Walsh0.00269,8893,379,001
07-May-2506-May-25BuyMatthew Baker held the position of Non-Executive Director at the time of this trade.Matthew Baker6.10GBX55,327292,902
07-May-2506-May-25BuyColin Walsh held the position of Non-Executive Director at the time of this trade.Colin Walsh6.10GBX221,33131,091,123
Fusion Antibodies

View share price, top shareholders, your shareholding, and interact with announcements for Fusion Antibodies plc.

Fusion Antibodies Home Page